Cannabis Operators Lock In Sub-6% Debt as Credit Window Slams Shut
By Sheeba M. | May 31, 2026 Cannabis Operators Lock In Sub-6% Debt as Credit Window Slams Shut TL;DR: Cannabis debt yields have collapsed to 5.8%-6.2% as institutional capital floods the sector. Major MSOs are locking in refinancing deals before the window closes—unlocking $400M+ in annual margin relief by late Q3. The cannabis credit market […]
Federal Rescheduling Odds Hit 60%—What It Means for MSO Valuations Now
By Sheeba M. | May 31, 2026 Federal Rescheduling Odds Hit 60%—What It Means for MSO Valuations Now TL;DR: Congressional sentiment on federal rescheduling is shifting faster than the market realizes. Section 280E relief alone could unlock $2-4B in unrealized cash flow across the MSO sector. Early movers in clean state footprints will benefit most. […]
Cannabis Companies Refinance Debt at Lower Rates—Window Closing Fast
By Sheeba M. | May 31, 2026 Cannabis Companies Refinance Debt at Lower Rates—Window Closing Fast TL;DR: Major MSOs and Canadian LPs are locking in refinancing deals ahead of potential rate hikes. Companies with near-term maturity walls (Curaleaf, Trulieve, Tilray) are most urgent—this window likely closes by Q3 2026. The cannabis capital markets are experiencing […]
New York Cuts Causal Retail License Timeline to 90 Days—Major Catalyst for Multi-State Operators
By Sheeba M. | May 30, 2026 New York Cuts Causal Retail License Timeline to 90 Days—Major Catalyst for Multi-State Operators TL;DR: New York’s expedited 90-day retail licensing track removes a major friction point for MSOs seeking non-adjacent expansion. Expect accelerated store openings across the Northeast by Q4 2026. New York’s Cannabis Control Board just […]
Cannabis ETFs See Institutional Buying Ahead of June Rebalancing
By Sheeba M. | May 30, 2026 Cannabis ETFs See Institutional Buying Ahead of June Rebalancing TL;DR: Large-cap cannabis ETFs are experiencing increased institutional inflow as fund managers rebalance portfolios heading into Q2 close. Watch for continued upward pressure on tier-1 operators through month-end. The cannabis sector is seeing a quiet rotation this week as […]
California’s Cultivator Supply Crisis: Why Indoor Grow Ops Are the 2026 M&A Play
By Sheeba M. | May 30, 2026 California’s Cultivator Supply Crisis: Why Indoor Grow Ops Are the 2026 M&A Play TL;DR: California outdoor cannabis supply has collapsed 40% YoY due to drought and regulatory delays. Indoor cultivators with licensed grow capacity are now acquisition targets for MSOs. Curaleaf and Trulieve are quietly building integrated supply […]
Trulieve Q1 Profit Inflection: EBITDA+ Territory After Five-Year Climb
By Sheeba M. | May 30, 2026 Trulieve Q1 Profit Inflection: EBITDA+ Territory After Five-Year Climb TL;DR: Trulieve’s journey from cash-burn to EBITDA profitability marks the inflection point for U.S. MSOs. With 226 stores, Best-in-Class unit economics, and federal tailwinds, TRUL is entering institutional prime time. Trulieve Cannabis (TRUL) reported Q1 2026 results last week—and […]
US MSO Consolidation Accelerates: What Federal Policy Shifts Mean for Your Portfolio
By Sheeba M. | May 30, 2026 US MSO Consolidation Accelerates: What Federal Policy Shifts Mean for Your Portfolio TL;DR: Multi-state operators are consolidating aggressively ahead of potential federal rescheduling, and early movers in this wave will capture the most value when banking access improves and institutional capital floods in. The US cannabis MSO sector […]
Canopy Growth Q4 Earnings Signal Recovery Path in Canadian Market
By Sheeba M. | May 30, 2026 Canopy Growth Q4 Earnings Signal Recovery Path in Canadian Market TL;DR: Canopy Growth’s latest quarterly results show improving margins and cost discipline, with management signaling profitability targets for fiscal 2025—a critical inflection point for Canada’s largest cannabis producer. Canopy Growth (CGC on TSX, CGBF on US OTC) reported […]
CBD Market Consolidation: Wall Street’s Next Play
By Sheeba M. | May 29, 2026 CBD Market Consolidation: Wall Street’s Next Play TL;DR: As CBD regulations normalize, larger cannabis operators are quietly acquiring standalone CBD brands. This consolidation wave mirrors Big Pharma M&A strategies—expect major announcements from CURLF and TCNNF within 12 months. The CBD market has reached an inflection point. What started […]